CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pivalizza, E. G.
Right arrow Articles by Weavind, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pivalizza, E. G.
Right arrow Articles by Weavind, L. M.

Canadian Journal of Anesthesia, Vol 44, 942-945, Copyright © 1997 by Canadian Anesthesiologists' Society

ARTICLES

Perioperative thromboelastography and sonoclot analysis in morbidly obese patients

EG Pivalizza, PJ Pivalizza and LM Weavind
Department of Anesthesiology, University of Texas Health Science Center, USA. epivaliz@anesl.med.uth.tmc.edu

PURPOSE: To investigate perioperative coagulation in morbidly obese (MO) patients with the thromboelastograph (TEG) and Sonoclot analyzer. METHODS: Twenty-six consecutive morbidly obese and 26 consecutive lean patients presenting for elective surgery were enrolled in this prospective, observational study. Blood was sampled for TEG and Sonoclot analysis immediately after anaesthetic induction and at the end of surgery in the MO group, and immediately after anaesthetic induction in the lean group. The R and K times, alpha angle, maximum amplitude and percentage fibrinolysis at 30 and 60 min were recorded from the TEG. The Sonoclot ACT, initial clot rate, peak amplitude and time to peak amplitude were recorded from the Sonoclot. RESULTS: The TEG in the MO group demonstrated decreased R and K times (8.6 +/- 4.8 vs 11.7 +/- 3.9 mm, and 2.8 +/- 1.2 vs 3.5 +/- 0.9 mm respectively (P < 0.05)), and increased alpha angle (73.7 +/- 6.0 vs 66.7 +/- 6.0 degrees, P < 0.05) and maximum amplitude (72.0 +/- 5.4 vs 67.9 +/- 4.4 mm, P < 0.05), without change in fibrinolysis. Sonoclot variables in the MO group included increased clot rate (37.5 +/- 11.5 vs 23.9 +/- 7.7%, P < 0.05) and decreased time to peak impedance (11.7 +/- 5.0 vs 17.5 +/- 7.2 min, P < 0.05), without change in Sonoclot ACT or peak signature impedance. CONCLUSION: The MO group demonstrated accelerated fibrin formation, fibrinogen-platelet interaction, and platelet function compared with lean controls but no difference in fibrinolysis. Viscoelastic measures of coagulation may be useful in MO patients, who are at increased risk of thromboembolic events.


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
A. B. Lerner, E. Sundar, F. Mahmood, T. Sarge, D. W. Hanto, and P. J. Panzica
Four Cases of Cardiopulmonary Thromboembolism During Liver Transplantation Without the Use of Antifibrinolytic Drugs
Anesth. Analg., December 1, 2005; 101(6): 1608 - 1612.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
E. G. Pivalizza, P. J. Pivalizza, S. Kee, L. I. Gottschalk, P. Szmuk, and D. C. Abramson
Sonoclot Analysis in Healthy Children
Anesth. Analg., April 1, 2001; 92(4): 904 - 906.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
E. Mahla, T. Lang, M. N. Vicenzi, G. Werkgartner, R. Maier, C. Probst, and H. Metzler
Thromboelastography for Monitoring Prolonged Hypercoagulability After Major Abdominal Surgery
Anesth. Analg., March 1, 2001; 92(3): 572 - 577.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Canadian Anesthesiologists' Society.